Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Robert Hauser

Professor of Neurology

Banner Alzheimer’s Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Neuropsychology Neuropsychology professors in United States

About

Robert Hauser is a Professor of Neurology at the USF Health Byrd Alzheimer's Institute in the United States. His research interests focus on movement disorders, particularly Parkinson's disease and tardive dyskinesia, as evidenced by his recent publications on related therapeutic strategies and treatment efficacy. He has contributed significantly to understanding the burden of tremor in Parkinson's disease and the safety of various pharmacological interventions.

Articles (13)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (3)

Joseph Friedman

Brown University

UNITED STATES

View details

Rohit Dhall

Professor and Chair

University of Arkansas for Medical Sciences

UNITED STATES

View details

Lorraine V. Kalia

Senior Scientist

University Health Network

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Hauser

Research Interests

Explore related searches

About

Articles (13)

Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results

DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real‐World Early Experience Program

LRRK2 as a Potential Disease‐Modifying Target in Sporadic Parkinson's Disease

Tardive dyskinesia versus tardive syndrome. What is in a name?

A validation study of the Clinician's Tardive Inventory (CTI)

Burden of tremor in Parkinson's disease: A survey study

Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA

Duration of “Good On” time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®)

How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson’s disease

Sedation and sleep safety of pimavanserin for Parkinsons’s disease psychosis: Review and exploratory analysis of clinical study data

Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use

A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease

Apomorphine titration with and without anti-emetic pretreatment in patients with Parkinson's disease experiencing OFF episodes: A modified Delphi panel

Collaborators (3)

Joseph Friedman

Rohit Dhall

Lorraine V. Kalia

Make your next move.